The Taa1 restriction enzyme provides a simple means to identify the Q368STOP mutation of the myocilin gene in primary open angle glaucoma
Publication Year 2001-04, Volume 131, Issue #4, Page 510-511
- Journal Title
- AMERICAN JOURNAL OF OPHTHALMOLOGY
- Publication Type
- Journal Article
- PURPOSE: To identify a rapid and reliable method to detect the Glutamine 368 STOP (Q368STOP) disease-predisposing allele of the myocilin gene associated with adult onset, primary, open-angle glaucoma. METHODS: Individuals with the Q368STOP mutation of the myocilin gene were identified from a cohort of primary open-angle glaucoma patients from Tasmania and subjected to Taa1 restriction digestion. RESULTS: In the Tasmanian family presented, screening with the Taa1 restriction enzyme successfully confirmed identification of all individuals with the Q368STOP mutation. CONCLUSIONS: The use of the Taa1 restriction enzyme offers a relatively simple, rapid, and reproducible technique that could be applied to detect the R368STOP mutation of the myocilin gene. (Am J Ophthalmol 2001;131:510-511. (C) 2001 by Elsevier Science Inc. All rights reserved).
- ELSEVIER SCIENCE INC
- Publisher's Version
- Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2001-04-01 12:00:00Last Modified: 0001-01-01 12:00:00